The Supreme Court Case That Could Slow Generic Drugs
In “Hikma v. Amarin,” the Supreme Court’s decision could affect how quickly generic versions of brand-name medicines come to market.
The independent source for health policy research, polling, and news.
Health care — and how much it costs — is scary. But you’re not alone with this stuff, and knowledge is power.
An Arm and a Leg, a podcast about these issues, is co-produced by host Dan Weissmann and KFF Health News. Previously, Weissmann was a staff reporter for Marketplace and Chicago’s WBEZ. His work also appears on “All Things Considered,” Marketplace, the BBC, 99% Invisible, and “Reveal” from the Center for Investigative Reporting.
Listen and Subscribe to “An Arm and a Leg” on iTunes, Pocket Casts, Google Play or Spotify.

Showing 1 - 20 of 133
In “Hikma v. Amarin,” the Supreme Court’s decision could affect how quickly generic versions of brand-name medicines come to market.
An Arm and a Leg launches its “101” series with the story of Alfred Engelberg, a lawyer who’s been crusading to improve access to generic drugs by fixing loopholes in a law he helped draft more than 40 years ago.
Two Americans explain how the skyrocketing cost of health insurance influenced their decision to buy — or skip — health insurance in 2026.
Ron Lieber, the “Your Money” columnist for The New York Times, shares ideas about how insurance companies, doctors, and patients can better handle prior authorization denials.
“An Arm and a Leg” host Dan Weissmann talks with the founder of the charity-care nonprofit Dollar For about how it helped eliminate $55 million in medical bills last year.
"An Arm and a Leg" looks back on state laws passed in 2025 aimed at removing medical debts from credit reports and reining in corporate influence on medicine.
As millions face skyrocketing health insurance premiums, the “An Arm and a Leg” team navigates their own limited options.
Good news for health care access this year includes new state laws to rein in prior authorization and medical debt collectors.
A longtime health economist sets her sights on lowering Americans’ insurance premiums.
A medical student’s DIY project brings “An Arm and a Leg” listeners together with new tools to fight medical debt.
The senior producer of “An Arm and a Leg” starts planning for health insurance in 2026, and — like millions of others signing up during this year’s open enrollment — faces a steep price increase.
A couple in New York thought they bought insurance. Instead, they got fake “jobs.”
In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider tips.
In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
An immigrant mathematician is on a mission to save U.S. hospitals billions of dollars and improve the lives of doctors, nurses, and patients. At one hospital, it's working.
Two stories from Washington, D.C., give listeners a sense of what changes the Trump administration has been making to health policy, with KFF Health News’ Julie Rovner and Arthur Allen.
An emergency room doctor says what the TV show “The Pitt” gets right about hospitals, including why they’re so crowded and the bills so high.
How one “Arm and a Leg” listener stayed encouraged during a two-year fight over a bill she didn’t owe.
The Consumer Financial Protection Bureau is offline — for now. Here’s what that could mean for people with medical debt.
“An Arm and a Leg” is collecting stories for a new series about how Americans get the medicine they need when faced with sticker shock.
© 2026 KFF